Allergist and immunologist Guillermo Ángeles Fernández warns that seasonal triggers like Saharan dust, dust mites, weather shifts, and pollution significantly worsen symptoms for patients managing allergic rhinitis and asthma, particularly during peak months between May and September. Speaking on the Luna TV segment Buenos días Doctor, Ángeles Fernández outlined how these environmental factors amplify respiratory inflammation for vulnerable populations.
Distinguishing Respiratory Allergies from Common Infections
Patients frequently confuse allergic rhinitis with a standard cold or viral flu because symptoms overlap heavily, including sneezing, nasal congestion, post-nasal drip, itching, and coughing. According to Ángeles Fernández, the primary diagnostic differentiator is duration and underlying cause. An infectious rhinitis typically resolves within roughly one week and frequently features a fever or purulent mucus. Conversely, allergic rhinitis persists indefinitely when patients remain exposed to specific environmental triggers.
The Centers for Disease Control and Prevention state that a standard common cold triggers congestion, runny nose, cough, sneezing, sore throat, headaches, and low-grade fevers. Meanwhile, the American Academy of Allergy, Asthma & Immunology (AAAAI) notes that true allergic rhinitis stems from indoor and outdoor allergens such as pollens, mold spores, animal dander, dust mites, and cockroach fragments. The AAAAI recommends formal skin prick testing or targeted blood analyses to accurately isolate these specific triggers.
The Impact of Saharan Dust and Environmental Shifts
Saharan dust storms do not inherently create de novo allergies in healthy individuals, but Ángeles Fernández notes that microparticulate matter severely exacerbates pre-existing conditions. These microscopic particles penetrate both upper and lower airways, intensifying inflammation in patients with chronic rhinitis and asthma. Recent clinical data links saharan dust exposure to heightened oxidative stress and inflammatory pathways that trigger acute asthma exacerbations.
Environmental management also requires controlling indoor physical variables. Ángeles Fernández points out that cold air currents, oscillating fans, air conditioning units, and sharp climate fluctuations heighten nasal hypersensitivity among allergic patients. While temperature swings in the Dominican Republic remain milder than in northern latitudes, distinct seasonal shifts still provoke surges in respiratory consultations.
Atopic March and Pediatric Considerations
Allergic diseases rarely stay confined to the nasal passages, frequently presenting across multiple organ systems through conditions like asthma, atopic dermatitis, chronic spontaneous urticaria, and food allergies. In pediatric populations, food triggers involving cow’s milk, eggs, tree nuts, or wheat often mark the onset of the atopic march—a clinical progression where infants transition from eczema into subsequent allergic rhinitis and asthma.
The AAAAI confirms that children with immediate family histories of atopic diseases face substantially elevated risks. While many children eventually outgrow specific food sensitivities, allergies to peanuts, tree nuts, fish, and shellfish frequently persist into adulthood. Ángeles Fernández emphasizes that genetic predisposition should not discourage proactive medical intervention. Modern allergy management successfully addresses hereditary risk factors through structured clinical protocols.
Advanced Biologic Therapies and Immunotherapy
Modern pharmacotherapy has transformed clinical outcomes for severe allergic conditions. Ángeles Fernández highlights the critical role of biologic therapies in managing severe asthma, atopic dermatitis, chronic urticaria, food allergies, and nasal polyposis for patients whose daily quality of life suffers severe disruption.
The U.S. Food and Drug Administration (FDA) has approved benralizumab as an add-on maintenance treatment for severe eosinophilic asthma in adult and pediatric patients aged six and older. Similarly, medical literature establishes omalizumab for allergic asthma and chronic spontaneous urticaria, alongside its recent application in reducing accidental food-allergen reactions in select patients. Without these specialized treatments, patients with severe asthma often face debilitating limitations, struggling with basic physical exertion or restful sleep due to chronic breathlessness.
For accurate diagnosis, Ángeles Fernández recommends starting with a comprehensive clinical history, followed by targeted skin tests, blood panels, patch tests for contact dermatitis, spirometry, or exhaled nitric oxide measurements. The AAAAI cautions that allergy tests require specialist interpretation to establish an exact treatment roadmap.
To reduce domestic exposure, Ángeles Fernández advises overhauling bedroom environments where dust mites accumulate. Minimizing storage boxes, physical books, heavy carpets, and nonessential items in sleeping areas directly curtails allergen loads. While many underlying allergic conditions remain chronic, targeted clinical control allows patients to achieve sustained symptom relief and restore their overall quality of life.
Keep reading